Senior Oral Wellness Family: One EV Base, Three Segments, US & EU Routes

The senior supplement shelf repeats two playbooks: relabeled multivitamins and unverifiable tonics. This playbook builds what's missing — a documented new-material family with segment-specific formulas, on US and EU routes.fiable tonics — a documented new-material family with segment-specific formulas is missing from the shelf.

01 · The problem

The senior supplement shelf repeats two playbooks: generic multivitamin matrices with new labels, or traditional tonics with thin documentation. Neither answers what adult-children buyers — the actual purchasers — increasingly ask for: a new-material story with traceable manufacturing and batch documentation, in segment-specific formulas rather than one beige product for everyone. No exosome-based senior family is on the shelf today — the first brand in sets the reference.

02 · Scientific rationale

The EV is a delivery vehicle, and that is the credible part: published human work on milk-derived exosomes showed encapsulation measurably improved a poorly bioavailable polyphenol's absorption over a two-week intervention. The family logic: one characterized EV base, formulated per segment — the brand launches a documented family, not isolated SKUs.

03 · Program documentation

Protocol documentation for this program family is maintained in TONGNIAN's internal files — network-clinic protocol series and anonymized case records where applicable [5]. Partner access under NDA; the evidence hierarchy stays explicit — published reviews first, internal observational programs second, case documentation third. [6]

Method anchors: [1] EV biology and cargo [2] MISEV2018 characterization [3] category evidence (review or registered study) [4] formulation and handling guidance [5] national measurement guideline (2026 No. 17) [6] internal protocol and case documentation.

04 · Product architecture

05 · Process & QC

EV material runs on the fully enclosed 0.5–5 L micro-batch line — closed-tubing culture, scheduled harvest, tangential-flow separation and concentration, sterile filtration — with low-shear handling qualified at process validation [4]. QC panel design follows MISEV2018 [2] and the national measurement guideline (2026 No. 17, TONGNIAN a drafting organization) [3].

Fig. 1 — The family map: one EV base, three senior segments.

06 · Regulatory pathway: EU & US first

US first: dietary-supplement positioning under DSHEA with structure/function-style label discipline. EU: food-supplement framework, novel-food assessment where ingredient history requires. China blue-hat is an additional market on the same base formula — the documentation chain serves all three.

07 · Expected outcomes

• Family launch economics: one baseline, three SKUs — development cost amortizes across the shelf presence.
• Gifting channel fit: 60-count jars bundle naturally into gift sets for holiday gifting seasons.
• Documentation depth is the premium argument on a shelf where it is rare.

No claims are made beyond the cosmetic, supplement, or professional-use framing of the destination market — authority comes from documentation and batch measurement.

08 · Commercial framework

Sample kits in 3–5 days; pilot from 500 units; production from 2,000 units; standard lead 15 workdays — all indicative, quoted per request. White-label and program naming run through the OBM program.

Request a quote · Line fact-sheet

References

1. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977.
2. Ávila-Gálvez MÁ, et al. Oral delivery of ellagic acid encapsulated in milk exosomes. Mol Nutr Food Res. 2026.
3. Cobetter. Exosomes Part I: Applications and Downstream Processing Overview. Technical review, 2025.
4. Guideline for Exosome Particle Size and Concentration Measurement (2026 No. 17), national standard — TONGNIAN, drafting organization.
5. TONGNIAN network clinics. Anonymized internal protocol and case documentation (partner access under NDA).